Agenus (AGEN) Operating Income (2010 - 2026)
Agenus' (AGEN) quarterly Operating Income came in at $15.1 million in Q1 2026, up 213.09% year-on-year from $4.8 million in Q1 2025, and up 4.56% quarter-over-quarter from $14.4 million in Q4 2025.
Agenus (AGEN) Operating Income (2010 - 2026) Analysis & Trends
Agenus' Operating Income history runs 17 years deep, the most recent figure standing at $15.1 million for Q1 2026.
- On a quarterly basis, Operating Income rose 213.09% year-over-year to $15.1 million in Q1 2026; TTM through Mar 2026 was $8.2 million, a 108.12% increase from a year earlier, with the FY2025 full-year figure at -$20.2 million, up 83.26% from the prior year.
- Operating Income improved to $15.1 million in Q1 2026 per AGEN's latest filing, from $14.4 million in the prior quarter.
- Across five years, Operating Income topped out at $15.1 million in Q1 2026 and bottomed at -$57.8 million in Q4 2022.
- The 5-year median for Operating Income is -$31.5 million (2024), against an average of -$27.3 million.
- Across the five-year window, Operating Income slumped 516.42% in 2024 and jumped 213.09% in 2026, its largest moves.
- Year by year, Operating Income stood at -$57.8 million in 2022, then surged by 92.73% to -$4.2 million in 2023, then slumped by 516.42% to -$25.9 million in 2024, then soared by 155.6% to $14.4 million in 2025, then advanced by 4.56% to $15.1 million in 2026.
- Per Business Quant, the three latest AGEN Operating Income figures stand at $15.1 million (Q1 2026), $14.4 million (Q4 2025), and -$4.5 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn | 15.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.05 Mn |
| Dec 31, 2025 | 14.40 Mn |
| Sep 30, 2025 | -4.55 Mn |
| Jun 30, 2025 | -16.71 Mn |
| Mar 31, 2025 | -13.31 Mn |
| Dec 31, 2024 | -25.90 Mn |
| Sep 30, 2024 | -31.50 Mn |
| Jun 30, 2024 | -30.19 Mn |
| Mar 31, 2024 | -32.88 Mn |
| Dec 31, 2023 | -4.20 Mn |
| Sep 30, 2023 | -46.34 Mn |
| Jun 30, 2023 | -54.67 Mn |
| Mar 31, 2023 | -54.34 Mn |
| Dec 31, 2022 | -57.76 Mn |
| Sep 30, 2022 | -41.65 Mn |
| Jun 30, 2022 | -44.57 Mn |
| Mar 31, 2022 | -35.46 Mn |
| Dec 31, 2021 | -54.03 Mn |
| Sep 30, 2021 | 187.54 Mn |
| Jun 30, 2021 | -66.40 Mn |